Page 14 - Practice Guidelines News Today

/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—a non-profit alliance of leading cancer centers across the United States—has released a...

TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or the “Company”) is...

/PRNewswire/ -- Evelyn Handel Zapata, PharmD, BCPS, BCOP, Senior Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network® (NCCN®)...

/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab...

DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc today announced that the European Commission has granted marketing authorization for Enrylaze® for use as a component of a...

/PRNewswire/ -- Outcomes4Me Inc., the developer of the first direct-to-patient, personalized and evidence-based cancer navigation platform, announced today it...

/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) 2023 Annual Congress: Hematologic Malignancies™ returns to San Francisco this week, for the...

NCCN 2023 Annual Congress: Hematologic Malignancies features expert perspectives on developments in blood cancer treatment, including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Updates, CAR T-Cell therapy, BTK Inhibitors, Bispecific T-Cell Engagers, and More. The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square. For full details and to register, visit NCCN.org/hem.

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.

Breast Cancer. NCCN Guidelines. Published March 2023. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf/ Accessed August 2023. European Society...